Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Plant Biol ; 20(1): 21, 2020 Jan 13.
Article in English | MEDLINE | ID: mdl-31931712

ABSTRACT

BACKGROUND: Triacylglycerols (TAGs) are the main composition of plant seed oil. Long-chain acyl-coenzyme A synthetases (LACSs) catalyze the synthesis of long-chain acyl-coenzyme A, which is one of the primary substrates for TAG synthesis. In Arabidopsis, the LACS gene family contains nine members, among which LACS1 and LACS9 have overlapping functions in TAG biosynthesis. However, functional characterization of LACS proteins in rapeseed have been rarely reported. RESULTS: An orthologue of the Arabidopsis LACS2 gene (BnLACS2) that is highly expressed in developing seeds was identified in rapeseed (Brassica napus). The BnLACS2-GFP fusion protein was mainly localized to the endoplasmic reticulum, where TAG biosynthesis occurs. Interestingly, overexpression of the BnLACS2 gene resulted in significantly higher oil contents in transgenic rapeseed plants compared to wild type, while BnLACS2-RNAi transgenic rapeseed plants had decreased oil contents. Furthermore, quantitative real-time PCR expression data revealed that the expression of several genes involved in glycolysis, as well as fatty acid (FA) and lipid biosynthesis, was also affected in transgenic plants. CONCLUSIONS: A long chain acyl-CoA synthetase, BnLACS2, located in the endoplasmic reticulum was identified in B. napus. Overexpression of BnLACS2 in yeast and rapeseed could increase oil content, while BnLACS2-RNAi transgenic rapeseed plants exhibited decreased oil content. Furthermore, BnLACS2 transcription increased the expression of genes involved in glycolysis, and FA and lipid synthesis in developing seeds. These results suggested that BnLACS2 is an important factor for seed oil production in B. napus.


Subject(s)
Brassica napus , Coenzyme A Ligases , Seeds/metabolism , Triglycerides/biosynthesis , Brassica napus/genetics , Brassica napus/metabolism , Coenzyme A Ligases/genetics , Coenzyme A Ligases/metabolism , Fatty Acids/biosynthesis , Gene Expression Regulation, Plant , Genes, Plant , Glycolysis/genetics , Lipid Metabolism/genetics , Plant Oils/metabolism , Plants, Genetically Modified/genetics , RNA Interference , Triglycerides/genetics
2.
J Med Chem ; 60(24): 10205-10219, 2017 12 28.
Article in English | MEDLINE | ID: mdl-29155585

ABSTRACT

SHP2, a cytoplasmic protein-tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways. SHP2 has been shown to contribute to the progression of a number of cancer types including leukemia, gastric, and breast cancers. It also regulates T-cell activation by interacting with inhibitory immune checkpoint receptors such as the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA). Thus, SHP2 inhibitors have drawn great attention by both inhibiting tumor cell proliferation and activating T cell immune responses toward cancer cells. In this study, we report the identification of an allosteric SHP2 inhibitor 1-(4-(6-bromonaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (23) that locks SHP2 in a closed conformation by binding to the interface of the N-terminal SH2, C-terminal SH2, and phosphatase domains. Compound 23 suppresses MAPK signaling pathway and YAP transcriptional activity and shows antitumor activity in vivo. The results indicate that allosteric inhibition of SHP2 could be a feasible approach for cancer therapy.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Enzyme Inhibitors/pharmacology , Naphthalenes/chemistry , Piperidines/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 11/antagonists & inhibitors , Thiazoles/chemistry , Adaptor Proteins, Signal Transducing/antagonists & inhibitors , Administration, Oral , Allosteric Regulation/drug effects , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Binding Sites , Cell Proliferation/drug effects , Crystallography, X-Ray , Drug Screening Assays, Antitumor , Enzyme Inhibitors/chemistry , Female , Humans , Inhibitory Concentration 50 , MAP Kinase Signaling System/drug effects , Mice, Inbred BALB C , Mice, Nude , Mutation , Naphthalenes/administration & dosage , Naphthalenes/pharmacokinetics , Phosphoproteins/antagonists & inhibitors , Piperidines/administration & dosage , Piperidines/pharmacokinetics , Protein Tyrosine Phosphatase, Non-Receptor Type 11/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism , Structure-Activity Relationship , Thiazoles/administration & dosage , Thiazoles/pharmacokinetics , Transcription Factors , Xenograft Model Antitumor Assays , YAP-Signaling Proteins
3.
Eur J Med Chem ; 132: 157-172, 2017 May 26.
Article in English | MEDLINE | ID: mdl-28350999

ABSTRACT

The inhibition of CYP17 to block androgen biosynthesis is a well validated strategy for the treatment of prostate cancer. Herein we reported the design, synthesis and structure-activity relationship (SAR) study for a series of novel 1,2,3,4- tetrahydrobenzo[4,5]thieno[2,3-c]pyridine derivatives. Some analogs demonstrated a potent inhibition to both rat and human CYP17 protein and reduced testosterone production in human H295R cell line. Some analogs also showed high selectivity against other CYP enzymes such as 3A4, 1A2, 2C9, 2C19 and 2D6, which may limit side effects due to drug-drug interactions. Among these analogs, the most potent compound 9c showed 1.5 fold more potent against rat and human CYP17 protein than that of abiraterone (IC50 = 16 nM and 20 nM vs. 25 nM and 36 nM respectively). In NCI-H295R cells, the inhibitory effect of compound 9c on testosterone production (52± 2%) was also more potent than that of abiraterone (74± 15%) at the concentration of 1 µM. Further, it was shown that 9c reduced plasma testosterone level in a dose-dependent manner in Sprague-Dawley rats. Thus, analog 9c maybe a potential agent used for the treatment of prostate cancer.


Subject(s)
Pyridines/chemical synthesis , Pyridines/pharmacology , Steroid 17-alpha-Hydroxylase/antagonists & inhibitors , Testosterone/antagonists & inhibitors , Androstenes/pharmacology , Animals , Cell Line , Drug Discovery , Humans , Inhibitory Concentration 50 , Male , Prostatic Neoplasms/drug therapy , Pyridines/chemistry , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship , Testosterone/biosynthesis , Testosterone/blood
4.
PLoS One ; 9(7): e100144, 2014.
Article in English | MEDLINE | ID: mdl-24992019

ABSTRACT

Seed storage oil, in the form of triacylglycerol (TAG), is degraded to provide carbon and energy during germination and early seedling growth by the fatty acid ß-oxidation in the peroxisome. Although the pathways for lipid degradation have been uncovered, understanding of the exact involved enzymes in soybean is still limited. Long-chain acyl-CoA synthetase (ACSL) is a critical enzyme that activates free fatty acid released from TAG to form the fatty acyl-CoA. Recent studies have shown the importance of ACSL in lipid degradation and synthesis, but few studies were focused on soybean. In this work, we cloned a ACSL gene from soybean and designated it as GmACSL2. Sequence analysis revealed that GmACSL2 encodes a protein of 733 amino acid residues, which is highly homologous to the ones in other higher plants. Complementation test showed that GmACSL2 could restore the growth of an ACS-deficient yeast strain (YB525). Co-expression assay in Nicotiana benthamiana indicated that GmACSL2 is located at peroxisome. Expression pattern analysis showed that GmACSL2 is highly expressed in germinating seedling and strongly induced 1 day after imbibition, which indicate that GmACSL2 may take part in the seed germination. GmACSL2 overexpression in yeast and soybean hairy root severely reduces the contents of the lipids and fatty acids, compared with controls in both cells, and enhances the ß-oxidation efficiency in yeast. All these results suggest that GmACSL2 may take part in fatty acid and lipid degradation. In conclusion, peroxisomal GmACSL2 from Glycine max probably be involved in the lipid degradation during seed germination.


Subject(s)
Coenzyme A Ligases/physiology , Glycine max/enzymology , Lipolysis , Peroxisomes/enzymology , Amino Acid Sequence , Coenzyme A Ligases/analysis , Coenzyme A Ligases/chemistry , Genetic Complementation Test , Germination , Metabolic Networks and Pathways , Molecular Sequence Data , Phylogeny , Plants, Genetically Modified , Seedlings/enzymology , Seedlings/growth & development , Seeds/enzymology , Seeds/growth & development , Sequence Alignment , Glycine max/genetics , Glycine max/metabolism , Nicotiana/genetics
5.
Mol Plant Pathol ; 15(7): 677-89, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24521393

ABSTRACT

Sclerotinia sclerotiorum causes a devastating disease in oilseed rape (Brassica napus) resulting in a tremendous yield loss worldwide. Studies on various host-pathogen interactions have shown that plant WRKY transcription factors are essential for defence. For the B. napus-S. sclerotiorum interaction, little direct evidence has been found with regard to the biological roles of specific WRKY genes in host resistance. In this study, we isolated a B. napus WRKY gene, BnWRKY33, and found that the gene is highly responsive to S. sclerotiorum infection. Transgenic B. napus plants overexpressing BnWRKY33 showed markedly enhanced resistance to S. sclerotiorum, constitutive activation of the expression of BnPR1 and BnPDF1.2, and inhibition of H2 O2 accumulation in response to pathogen infection. Further, we isolated a mitogen-activated protein (MAP) kinase substrate gene, BnMKS1, and found that not only can BnWRKY33 interact with BnMKS1, which can also interact with BnMPK4, using the yeast two-hybrid assay, consistent with their collective nuclear localization, but also BnWRKY33, BnMKS1 and BnMPK4 are substantially and synergistically expressed in response to S. sclerotiorum infection. In contrast, the three genes showed differential expression in response to phytohormone treatments. Together, these results suggest that BnWRKY33 plays an important role in B. napus defence to S. sclerotiorum, which is most probably associated with the activation of the salicylic acid (SA)- and jasmonic acid (JA)-mediated defence response and inhibition of H2 O2 accumulation, and we propose a potential mechanism in which BnMPK4-BnMKS1-BnWRKY33 exist in a nuclear localized complex to regulate resistance to S. sclerotiorum in oilseed rape.


Subject(s)
Ascomycota/pathogenicity , Brassica/genetics , Drug Resistance, Fungal/genetics , Plant Proteins/genetics , Brassica/metabolism , Brassica/microbiology , Hydrogen Peroxide/metabolism , Molecular Sequence Data , Plants, Genetically Modified , Subcellular Fractions/metabolism
6.
Plant Sci ; 184: 75-82, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22284712

ABSTRACT

Signaling pathways mediated by salicylic acid (SA) and jasmonic acid (JA) are widely studied in various host-pathogen interactions. For oilseed rape (Brassica napus)-Sclerotinia sclerotiorum interaction, little information of the two signaling molecules has been described in detail. In this study, we showed that the level of SA and JA in B. napus leaves was increased with a distinct temporal profile, respectively, after S. sclerotiorum infection. The application of SA or methyl jasmonate enhanced the resistance to the pathogen. Furthermore, a set of SA and JA signaling marker genes were identified from B. napus and were used to monitor the signaling responses to S. sclerotiorum infection by examining the temporal expression profiles of these marker genes. The SA signaling was activated within 12h post inoculation (hpi) followed by the JA signaling which was activated around 24 hpi. In addition, SA-JA crosstalk genes were activated during this process. These results suggested that defense against S. sclerotiorum in oilseed rape is associated with a sequential activation of SA signaling and JA signaling, which provide important clues for designing strategies to curb diseases caused by S. sclerotioru.


Subject(s)
Ascomycota/physiology , Brassica napus/immunology , Brassica napus/microbiology , Cyclopentanes/metabolism , Oxylipins/metabolism , Salicylic Acid/metabolism , Signal Transduction , Ascomycota/drug effects , Brassica napus/drug effects , Brassica napus/genetics , Cyclopentanes/pharmacology , Gene Expression Profiling , Gene Expression Regulation, Plant/drug effects , Genes, Plant/genetics , Oxylipins/pharmacology , Plant Diseases/genetics , Plant Diseases/microbiology , Plant Leaves/drug effects , Plant Leaves/genetics , Plant Leaves/microbiology , Salicylic Acid/pharmacology , Signal Transduction/drug effects , Signal Transduction/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...